trial,pubID,pseudogroup,weeks,group,IgD-/IgM-/IgA-/IgG+/Antigen++ B cells
G002,G002-852,G002,24,1,8287.0
G002,G002-678,G002,24,1,9305.0
G002,G002-509,G002,24,1,4179.0
G002,G002-813,G002,24,1,4425.0
G002,G002-502,G002,24,1,4879.0
G002,G002-758,G002,24,1,4930.0
G002,G002-616,G002,24,1,1725.0
G002,G002-546,G002,24,1,4233.0
G002,G002-302,G002,24,1,5236.0
G002,G002-969,G002,24,1,2908.0
G002,G002-619,G002,24,1,2197.0
G002,G002-905,G002,24,1,2199.0
G002,G002-834,G002,24,1,441.0
